SG11201808976WA - Method of producing a recombinant protein - Google Patents

Method of producing a recombinant protein

Info

Publication number
SG11201808976WA
SG11201808976WA SG11201808976WA SG11201808976WA SG11201808976WA SG 11201808976W A SG11201808976W A SG 11201808976WA SG 11201808976W A SG11201808976W A SG 11201808976WA SG 11201808976W A SG11201808976W A SG 11201808976WA SG 11201808976W A SG11201808976W A SG 11201808976WA
Authority
SG
Singapore
Prior art keywords
glaxosmithkline
road
international
hertfordshire
recombinant protein
Prior art date
Application number
SG11201808976WA
Other languages
English (en)
Inventor
Robyn Alexandra Emmins
Gary Brian Finka
Michael Hoare
Alan Peter Lewis
William John Kenneth Lewis
Adam Daniel Mcinally
Mark Uden
Ioannis Voulgaris
Original Assignee
Glaxosmithkline Ip Dev Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Ip Dev Ltd filed Critical Glaxosmithkline Ip Dev Ltd
Publication of SG11201808976WA publication Critical patent/SG11201808976WA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/22—Vectors comprising a coding region that has been codon optimised for expression in a respective host

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
SG11201808976WA 2016-05-06 2017-05-04 Method of producing a recombinant protein SG11201808976WA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662332636P 2016-05-06 2016-05-06
US201662338045P 2016-05-18 2016-05-18
PCT/EP2017/060654 WO2017191255A1 (en) 2016-05-06 2017-05-04 Method of producing a recombinant protein

Publications (1)

Publication Number Publication Date
SG11201808976WA true SG11201808976WA (en) 2018-11-29

Family

ID=58765814

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201808976WA SG11201808976WA (en) 2016-05-06 2017-05-04 Method of producing a recombinant protein

Country Status (14)

Country Link
US (1) US11098312B2 (cg-RX-API-DMAC7.html)
EP (1) EP3452496A1 (cg-RX-API-DMAC7.html)
JP (2) JP2019516371A (cg-RX-API-DMAC7.html)
KR (1) KR102504317B1 (cg-RX-API-DMAC7.html)
CN (1) CN109071611B (cg-RX-API-DMAC7.html)
AU (1) AU2017260277A1 (cg-RX-API-DMAC7.html)
BR (1) BR112018072043A2 (cg-RX-API-DMAC7.html)
CA (1) CA3023025A1 (cg-RX-API-DMAC7.html)
IL (1) IL262544A (cg-RX-API-DMAC7.html)
MX (1) MX2018013562A (cg-RX-API-DMAC7.html)
RU (1) RU2742006C2 (cg-RX-API-DMAC7.html)
SG (1) SG11201808976WA (cg-RX-API-DMAC7.html)
TW (1) TWI794170B (cg-RX-API-DMAC7.html)
WO (1) WO2017191255A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020165874A1 (en) * 2019-02-15 2020-08-20 Oncosimis Biotech Private Limited A bacterial expression vector for enhanced protein secretion
KR102094480B1 (ko) 2019-05-27 2020-04-01 (주)엘에스케이화인텍스 재사용 가능한 미세 먼지 항균 마스크
CN110551199B (zh) * 2019-09-26 2022-01-25 杭州纽龙日尚生物制品有限公司 一种提高工程菌分泌表达重组人表皮生长因子的方法
KR20240021234A (ko) 2021-06-10 2024-02-16 펠리칸 테크놀로지 홀딩스, 인크. 재조합 단백질 발현을 위한 박테리아 숙주

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1546342A2 (en) * 2002-09-20 2005-06-29 Cym1P A/S Methods for increasing the production of a recombinant polypeptide from a host cell
GB0426160D0 (en) * 2004-11-29 2004-12-29 Era Plantech S L Production of proteins
KR100981356B1 (ko) * 2006-01-31 2010-09-14 대한민국 신호서열 및 변이된 신호서열로 디자인된 분비증강자에의한 원래 형태의 수용성 재조합 단백질 생산 방법
GB0602173D0 (en) 2006-02-03 2006-03-15 Avecia Ltd Expression system
WO2009021548A1 (en) * 2007-08-10 2009-02-19 Wacker Chemie Ag Expression of full length igg and secretion into the culture medium of prokaryotic cells
RU2488635C1 (ru) * 2012-03-22 2013-07-27 Государственное бюджетное образовательное учреждение высшего профессионального образования Первый Московский государственный медицинский университет им. И.М. Сеченова Министерства здравоохранения и социального развития Российской Федерации (ГБОУ ВПО Первый МГМУ им. И.М. Сеченова Минздравсоцразвития Способ получения рекомбинантного антиангиогенного полипептида
US20140244228A1 (en) * 2012-09-19 2014-08-28 Agency For Science, Technology And Research Codon optimization of a synthetic gene(s) for protein expression

Also Published As

Publication number Publication date
US20190177734A1 (en) 2019-06-13
JP2019516371A (ja) 2019-06-20
AU2017260277A1 (en) 2018-11-22
IL262544A (en) 2018-12-31
KR102504317B1 (ko) 2023-02-24
RU2742006C2 (ru) 2021-02-01
KR20190003694A (ko) 2019-01-09
BR112018072043A2 (pt) 2019-02-12
CN109071611B (zh) 2022-11-01
RU2018137305A (ru) 2020-06-08
US11098312B2 (en) 2021-08-24
CA3023025A1 (en) 2017-11-09
WO2017191255A1 (en) 2017-11-09
TW201805298A (zh) 2018-02-16
TWI794170B (zh) 2023-03-01
JP2022070902A (ja) 2022-05-13
MX2018013562A (es) 2019-03-14
RU2018137305A3 (cg-RX-API-DMAC7.html) 2020-06-08
CN109071611A (zh) 2018-12-21
EP3452496A1 (en) 2019-03-13

Similar Documents

Publication Publication Date Title
SG11201807252QA (en) Anti-lag-3 antibodies
SG11201809857TA (en) Anti-CTLA-4 Antibodies
SG11201810983PA (en) Novel heterocyclic derivatives useful as shp2 inhibitors
SG11201903830TA (en) Blockade of cd7 expression and chimeric antigen receptors for immunotherapy of t-cell malignancies
SG11201903302UA (en) Bispecific heterodimeric fusion proteins containing il-15/il-15ralpha fc-fusion proteins and pd-1 antibody fragments
SG11201806541RA (en) Image classification and labeling
SG11201808724SA (en) Anti-tim-3 antibodies and compositions
SG11201805040UA (en) Cell reprogramming
SG11201804460PA (en) Calibration and detection techniques in haptic systems
SG11201808797XA (en) T cell receptors
SG11201808821WA (en) Agonistic antibodies that bind human cd40 and uses thereof
SG11201909070RA (en) System for hydrocarbon recovery
SG11201810975UA (en) Method for stabilizing proteins
SG11201810989VA (en) Systems and methods for route planning
SG11201811604UA (en) System and method for real-time transcription of an audio signal into texts
SG11201811659PA (en) Systems and methods for determining an estimated time of arrival
SG11201808992UA (en) Compositions and methods for the detection of host cell proteins
SG11201805494WA (en) Mutated von willebrand factor
SG11201906359SA (en) Compositions and methods for maturation of oocytes in vitro
SG11201806432PA (en) Methods for assessing risk of developing colorectal cancer
SG11201901172QA (en) A method for manufacturing a fuel component
SG11201803565UA (en) Cd131 binding proteins and uses thereof
SG11201811238YA (en) Systems and methods for stations loading and display
SG11201900474RA (en) Improvements to aircraft taxiing
SG11201804708WA (en) A controllable float module, a modular offshore structure assembly comprising at least one controllable float module and a method for assembling a modular offshore structure in situ